Delivery Order SPE2DB22D3301-SPE2DB25FY2DK

Award Date 3/25/25
Potential Completion Date 4/15/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,016.24 firm fixed price delivery order is for the provision of 100 mg vials of the specialty pharmaceutical ENHERTU. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,099.62 firm-fixed-price delivery order is for the pharmaceutical product ENHERTU 100 MG VIALS, with a completion date of December 27, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $16,832.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ENHERTU 100 MG vials, a specialty medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $13,016.24 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4566023708 ENHERTU 100 MG VIALS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a range of medical commodities to military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,099.62 firm fixed-price delivery order is for the supply of ENHERTU 100 MG vials, a specialty medication. The award has an ultimate completion date of December 23, 2024 and is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $17,777.00 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. The contract covers the procurement of ENHERTU 100 MG VIALS, a pharmaceutical product, for DLA and does not have a set-aside designation. Amerisourcebergen holds a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,466.16 Firm Fixed Price Delivery Order is for the supply of ENHERTU 100 MG vials, a specialty medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,733.08 Firm Fixed Price Delivery Order is for the supply of ENHERTU 100 MG vials, a specialty oncology medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,149.34 firm fixed-price delivery order is for the supply of ENHERTU 100 MG vials, a specialty medication. The contract has a completion date of January 3, 2025 and was awarded on December 11, 2024. No set-aside requirements were utilized for this procurement. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,016.24, is for the supply of ENHERTU 100 MG VIALS, a specialty pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2DK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,110.80 firm fixed-price delivery order is for the pharmaceutical product ENHERTU 100 MG VIALS. The contract has an ultimate completion date of April 15, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/24/25, 9:52 AM